THRD
Third Harmonic Bio Inc.
NASDAQ: THRD · HEALTHCARE · BIOTECHNOLOGY
$5.38
+0.00% today
Updated 2026-04-29
Market cap
$242.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.24
Dividend yield
—
52W range
$5 – $6
Volume
—
Third Harmonic Bio Inc. (THRD) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $8.43M | $129.16M | $298.68M | $277.71M | $294.61M |
| Cash & equivalents | $8.28M | $128.28M | $288.88M | $269.07M | $285.06M |
| Current assets | $8.43M | $129.16M | $292.83M | $272.45M | $290.54M |
| Total liabilities | $26.79M | $175.87M | $9.61M | $8.63M | $9.46M |
| Current liabilities | $2.21M | $5.69M | $5.65M | $5.42M | $7.11M |
| Long-term debt | — | — | — | — | — |
| Shareholder equity | $342000.00 | $123.48M | $289.07M | $269.08M | $285.15M |
| Retained earnings | $-18.63M | $-48.24M | $-83.40M | $-114.22M | $-159.69M |
| Accounts receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |